苏加马德克斯对凝血的作用:系统性审查和元分析
Yu-Hsun Tsai1, Ming-Chang Kao2, Hsi-Ning Kao3
1Department of Anesthesiology, New Taipei Municipal TuCheng Hospital, No. 6, Sec. 2, Jincheng Rd., Tucheng Dist, New Taipei City, 236017, Taiwan.
BMC anesthesiology
|April 24, 2025
概括
苏加马德克斯可能会暂时增加前热血素时间 (PT),但不会影响激活的部分血栓形成时间 (APTT). 对于健康患者来说,常规监测是不必要的,但对于高危人群来说,建议谨慎.
科学领域:
- 麻醉学和药理学 麻醉学和药理学
背景情况:
- 苏加马德克斯快速逆转罗库诱导的神经肌肉阻塞.
- 苏加马德克斯有可能影响凝血和出血.
研究的目的:
- 调查sugammadex对凝血参数的影响.
- 评估对前列血时间 (PT) 和激活的部分血栓形成时间 (APTT) 的影响.
主要方法:
- 在Cochrane,Embase和PubMed数据库中进行系统搜索.
- 包括随机对照试验 (RCT) 评估sugammadex和凝血.
- 来自1302名参与者的四个RCT数据的元分析.
主要成果:
- 苏加马德克斯 (Sugammadex) 的使用与延长的前热血素时间 (PT) 有关.
- 没有观察到对激活的部分血栓形成时间 (APTT) 的显著影响.
- 确定了5个RCT,共有1328名参与者.
结论:
- 苏加马德克斯可能会导致PT的暂时增加,但不会改变APTT.
- 常规凝血监测通常不需要健康个体.
- 高风险患者需要个性化凝血评估;对特定人群需要进一步研究.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
545
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
545
Depolarizing Blockers: Pharmocokinetics
289
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
289
Extrinsic and Intrinsic Pathways of Hemostasis
3.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
3.6K


